VC DEALS ANALYSIS: 2016 Bucks January Trend With Flying Start
This article was originally published in Clinica
Executive Summary
January is traditionally a slow month for venture funding deals but 2016 is already distinguishing itself from the previous years with total deal value exceeding well above $600m in the first month.
You may also be interested in...
VC Deals Analysis: LabCorp Puts Money On January's Biggest Round
2017 has not got off to a bullish start, with January’s total venture financing deal value barely making it half way past last year’s level. The biggest round, at $40m, went to preterm birth risk specialist Sera Prognostics, catching the eye of the largest lab services provider in the US, LabCorp.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.